Premium Information is available for this item - Upgrade for $1 a day
6505-01-260-7876
Usp Chlorprothixene Tablets
6505012607876 012607876 TARACTAN TABLETS 77824 NDC00004-0046-01
INC: 35944 Chlorprothixene Tablets
January 2023
5
Marketplace 6505-01-260-7876
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-260-7876 5+ Documents (More...)
,MBEU 77824 ) https//www.nsnlookup.com https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-260-7876
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-260-7876 Usp Chlorprothixene Tablets 6505012607876
Tablets6505012614852 012614852TARACTAN TABLETS https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-260-7876
Usp Chlorprothixene Tablets 6505012607876 Upgrade your Account Upgrade 6505-01-260-7876Usp Chlorprothixene
Tablets6505012607876 012607876 TARACTAN www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-260-7876 Usp Chlorprothixene
Tablets 6505012607876 TARACTAN TABLETS Tablets6505012614852 012614852 TARACTAN 151209726 https//www.nsnlookup.com
-99-771-6920 Label 7690997716920997716920 7690-99 -771-6920 Label 7690997716920997716920,MBEU 77824
https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-260-7876 Usp Chlorprothixene Tablets 6505012607876
Usp Chlorprothixene Tablets 6505012607876 www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-260-7876
Usp Chlorprothixene Tablets 6505012607876 014055536 K753X77824K753 77824 Usp Chlorprothixene Tablets
Restrictions 6505-01-260-7876
6505-01-260-7876 is a Usp Chlorprothixene Tablets that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-260-7876
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-260-7876
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-260-7876
- Part Number
- Manufacturer
- Status
- 77824
- Manufacturer
- 66002 - Roche Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- NDC00004-0046-01
- 66002 - Roche Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- TARACTAN TABLETS
- 66002 - Roche Laboratories Inc. (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
Datasheet 6505-01-260-7876
- Characteristic
- Specifications
- FIIG
- Specifications
- A510N0
- Active Medicament Medicinal Strength [AKJA]
- 25.000 Milligrams Chlorprothixene Active Ingredient
- Administration [CSGS]
- Oral
- Primary Container Type [CQCT]
- Bottle
- Primary Container Content Quantity [CRLK]
- 100.000 Tablets
Similar Supply Items to 6505-01-260-7876
Freight Information 6505-01-260-7876
6505-01-260-7876 has freight characteristics.. 6505-01-260-7876 has a variance between NMFC and UFC when transported by rail and the description should be consulted.